Value Walk: How To Boost Drug Companies’ Profits Without Hurting Poor Americans - 340B Matters
15648
post-template-default,single,single-post,postid-15648,single-format-standard,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-9.1.3,wpb-js-composer js-comp-ver-4.11.1,vc_responsive

18 May Value Walk: How To Boost Drug Companies’ Profits Without Hurting Poor Americans

A Free Market Reform that Can Help Everybody

Drug companies, like all for-profit companies, are all about profits. Their basic job is to take investors’ money and use it to get more money. Unfortunately, one major source of those bucks is Washington, DC — and government money always comes with strings attached.

Companies that rely on government have two goals: maximize the cash flowing in and minimize the strings that come with it. Drug companies’ latest target in this game is the 340B federal drug discount program.

Read more.

 

 

Want To Stay Up-To-Date On The Latest 340B News?